相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design and linkage optimization of ursane-thalidomide-based PROTACs and identification of their targeted-degradation properties to MDM2 protein
Zhiwen Qi et al.
BIOORGANIC CHEMISTRY (2021)
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
Tyler B. Faust et al.
NATURE CHEMICAL BIOLOGY (2020)
Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs
Hongying Gao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Hi-JAK-ing the ubiquitin system: The design and physicochemical optimisation of JAK PROTACs
Rishi R. Shah et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem et al.
CELL (2020)
Development of selective mono or dual PROTAC degrader probe of CDK isoforms
Fei Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeted selective degradation of Bruton's tyrosine kinase by PROTACs
Shaodong Liu et al.
MEDICINAL CHEMISTRY RESEARCH (2020)
Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
Maria Maneiro et al.
ACS CHEMICAL BIOLOGY (2020)
Two-Stage Strategy for Development of Proteolysis Targeting Chimeras and its Application for Estrogen Receptor Degraders
Brett L. Roberts et al.
ACS CHEMICAL BIOLOGY (2020)
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
Sajid Khan et al.
ONCOGENE (2020)
A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL
Bingqi Tong et al.
ACS CHEMICAL BIOLOGY (2020)
HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
Matthias Schiedel et al.
CHEMBIOCHEM (2020)
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Anja Vogelmann et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
Mei Zeng et al.
CELL CHEMICAL BIOLOGY (2020)
Treatment of Alzheimer’s by PROTAC-Tau Protein Degradation
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2019)
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications
Carl C. Ward et al.
ACS CHEMICAL BIOLOGY (2019)
From Inhibition to Degradation: Targeting the Antiapoptotic Protein Myeloid Cell Leukemia 1 (MCL1)
James W. Papatzimas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Harnessing the anti-cancer natural product nimbolide for targeted protein degradation
Jessica N. Spradlin et al.
NATURE CHEMICAL BIOLOGY (2019)
Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16
Xiaoyu Zhang et al.
NATURE CHEMICAL BIOLOGY (2019)
Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders
Jiuling Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands
Ziqian Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase
Quanju Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Light-Induced Protein Degradation with Photocaged PROTACs
Gang Xue et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
John Hines et al.
CANCER RESEARCH (2019)
Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)
Jiantao Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Targeted Degradation of MDM2 as a New Approach to Improve the Efficacy of MDM2-p53 Inhibitors
Ryan P. Wurz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands
Xin Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Blake E. Smith et al.
NATURE COMMUNICATIONS (2019)
Developing potent PROTACs tools for selective degradation of HDAC6 protein
Zixuan An et al.
PROTEIN & CELL (2019)
Solid-phase synthesis for thalidomide-based proteolysis-targeting chimeras (PROTAC)
S. Krajcovicova et al.
CHEMICAL COMMUNICATIONS (2019)
Bivalent Ligands for Protein Degradation in Drug Discovery
Marcel Scheepstra et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands
Norihito Shibata et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression
Bing Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells
B. Sun et al.
LEUKEMIA (2018)
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
Calla M. Olson et al.
NATURE CHEMICAL BIOLOGY (2018)
Targeting the C481S Ibrutinib-Resistance Mutation in Bruton's Tyrosine Kinase Using PROTAC-Mediated Degradation
Alexandru D. Buhimschi et al.
BIOCHEMISTRY (2018)
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
Yonghui Sun et al.
CELL RESEARCH (2018)
Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)
Chengwei Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor degradation
Nobumichi Ohoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression
Chong Qin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
Lara N. Gechijian et al.
NATURE CHEMICAL BIOLOGY (2018)
Homo-PROTACs for the Chemical Knockdown of Cereblon
Christian Steinebach et al.
ACS CHEMICAL BIOLOGY (2018)
Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy
Tao Yuan et al.
FRONTIERS IN PHARMACOLOGY (2018)
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
Hai-Tsang Huang et al.
CELL CHEMICAL BIOLOGY (2018)
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson et al.
CELL CHEMICAL BIOLOGY (2018)
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
George M. Burslem et al.
CELL CHEMICAL BIOLOGY (2018)
Development of Stabilized Peptide-Based PROTACs against Estrogen Receptor alpha
Yanhong Jiang et al.
ACS CHEMICAL BIOLOGY (2018)
In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)
Nobumichi Ohoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells
D. T. Saenz et al.
LEUKEMIA (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
Targeted protein degradation by PROTACs
Taavi K. Neklesa et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs
Christopher G. Parker et al.
ACS CENTRAL SCIENCE (2017)
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
David Remillard et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
Ashton C. Lai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Small-Molecule PROTACS: New Approaches to Protein Degradation
Momar Toure et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy
Nobumichi Ohoka et al.
CURRENT CANCER DRUG TARGETS (2016)
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Kanak Raina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras
Honorine Lebraud et al.
ACS CENTRAL SCIENCE (2016)
Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent Necroptosis
Dianrong Li et al.
CELL CHEMICAL BIOLOGY (2016)
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Michael Zengerle et al.
ACS CHEMICAL BIOLOGY (2015)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Natural products triptolide, celastrol, and withaferin A inhibit the chaperone activity of peroxiredoxin I
Qian Zhao et al.
CHEMICAL SCIENCE (2015)
Protein quality control and elimination of protein waste: The role of the ubiquitin-proteasome system
Ingo Amm et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Effects of 25-hydroxy-cholecalciferol on the development of osteochondrosis in swine
Toshie Sugiyama et al.
ANIMAL SCIENCE JOURNAL (2013)
Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1a
Dennis L. Buckley et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Targeting the von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
Dennis L. Buckley et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
A. Lopez-Girona et al.
LEUKEMIA (2012)
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome
Young-Ki Paik et al.
NATURE BIOTECHNOLOGY (2012)
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
Chuan-Xu Liu et al.
NATURE CHEMICAL BIOLOGY (2012)
Identification of Direct Protein Targets of Small Molecules
Brett Lomenick et al.
ACS CHEMICAL BIOLOGY (2011)
Impact of linker length on the activity of PROTACs
Kedra Cyrus et al.
MOLECULAR BIOSYSTEMS (2011)
Jostling for Position: Optimizing Linker Location in the Design of Estrogen Receptor-Targeting PROTACs
Kedra Cyrus et al.
CHEMMEDCHEM (2010)
Protein Knockdown Using Methyl Bestatin-Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins
Yukihiro Itoh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Identification of C10 biotinylated camptothecin (CPT-10-B) binding peptides using T7 phage display screen on a QCM device
Yoichi Takakusagi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin
Paola Bargagna-Mohan et al.
CHEMISTRY & BIOLOGY (2007)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients?
X Chen et al.
NATURAL PRODUCT REPORTS (2003)
Protein chip technology
H Zhu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
分享论文
